Joly AH - Search Results

1

Inhibition of the mitogen activated protein kinase, p38 alpha, prevents proinflammatory cytokine induction by human adherent mononuclear leukocytes in response to lipid loading.

Feng Y, Schreiner GF, Chakravarty S, Liu DY, Joly AH. Feng Y, et al. Among authors: joly ah. Atherosclerosis. 2001 Oct;158(2):331-8. doi: 10.1016/s0021-9150(01)00453-1. Atherosclerosis. 2001. PMID: 11583711

2

CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.

Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. Chen MM, et al. Among authors: joly ah. J Mol Cell Cardiol. 2000 Oct;32(10):1805-19. doi: 10.1006/jmcc.2000.1215. J Mol Cell Cardiol. 2000. PMID: 11013125

3

Insulin-like growth factor-binding protein-3 induces fetalization in neonatal rat cardiomyocytes.

Henson M, Damm D, Lam A, Garrard LJ, White T, Abraham JA, Schreiner GF, Stanton LW, Joly AH. Henson M, et al. Among authors: joly ah. DNA Cell Biol. 2000 Dec;19(12):757-63. doi: 10.1089/104454900750058116. DNA Cell Biol. 2000. PMID: 11177573

4

Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.

Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: joly ah. J Am Soc Nephrol. 2001 Jul;12(7):1434-1447. doi: 10.1681/ASN.V1271434. J Am Soc Nephrol. 2001. PMID: 11423572

5

Neutral lipid from proteinuric rat urine is a novel inhibitor of the red blood cell calcium pump.

Lindner A, Hinds TR, Joly A, Schreiner GF. Lindner A, et al. J Am Soc Nephrol. 1999 Jun;10(6):1170-8. doi: 10.1681/ASN.V1061170. J Am Soc Nephrol. 1999. PMID: 10361854

6

Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling.

Ge R, Rajeev V, Subramanian G, Reiss KA, Liu D, Higgins L, Joly A, Dugar S, Chakravarty J, Henson M, McEnroe G, Schreiner G, Reiss M. Ge R, et al. Biochem Pharmacol. 2004 Jul 1;68(1):41-50. doi: 10.1016/j.bcp.2004.03.011. Biochem Pharmacol. 2004. PMID: 15183116

7

Evidence for inflammatory and secretagogue lipids in cyst fluids from patients with autosomal dominant polycystic kidney disease.

Grantham JJ, Schreiner GF, Rome L, Grenz L, Joly A. Grantham JJ, et al. Proc Assoc Am Physicians. 1997 Jul;109(4):397-408. Proc Assoc Am Physicians. 1997. PMID: 9220537

8

Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.

Suga S, Kim YG, Joly A, Puchacz E, Kang DH, Jefferson JA, Abraham JA, Hughes J, Johnson RJ, Schreiner GF. Suga S, et al. Kidney Int. 2001 Oct;60(4):1297-308. doi: 10.1046/j.1523-1755.2001.00935.x. Kidney Int. 2001. PMID: 11576344 Free article.

9

Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus.

Twigg SM, Chen MM, Joly AH, Chakrapani SD, Tsubaki J, Kim HS, Oh Y, Rosenfeld RG. Twigg SM, et al. Among authors: joly ah. Endocrinology. 2001 May;142(5):1760-9. doi: 10.1210/endo.142.5.8141. Endocrinology. 2001. PMID: 11316739

10

Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts.

Twigg SM, Joly AH, Chen MM, Tsubaki J, Kim HS, Hwa V, Oh Y, Rosenfeld RG. Twigg SM, et al. Among authors: joly ah. Endocrinology. 2002 Apr;143(4):1260-9. doi: 10.1210/endo.143.4.8741. Endocrinology. 2002. PMID: 11897682

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page